John Armitage Egerton Capital (UK)
John Armitage is the chief investment officer of Egerton Capital, a London-based long/short equity firm. Egerton is known for fundamental research and a portfolio of high-quality global companies, often with a growth-at-a-reasonable-price tilt. Institutional investors follow the firm for its long track record in developed-market equities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$748M |
| 2 |
Linde
LIN
|
+$504M |
| 3 |
NVIDIA
NVDA
|
+$491M |
| 4 |
Moody's
MCO
|
+$365M |
| 5 |
Devon Energy
DVN
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$846M |
| 2 |
Amazon
AMZN
|
+$777M |
| 3 |
Boston Scientific
BSX
|
+$513M |
| 4 |
Capital One
COF
|
+$501M |
| 5 |
Wynn Resorts
WYNN
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 34.61% |
| 2 | Materials | 14.44% |
| 3 | Technology | 12.92% |
| 4 | Communication Services | 11.92% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Visa
V
$693B
| $1.24B | 13.79% |
4,110,970
+839,971
| +26% | +$270M |
|
|
2
Alphabet (Google) Class C
GOOG
$4.18T
| $992M | 11.01% |
3,459,649
+2,380,881
| +221% | +$748M |
|
|
3
Moody's
MCO
$87.2B
| $674M | 7.48% |
1,545,670
+772,261
| +100% | +$365M |
|
|
4
Linde
LIN
$225B
| $530M | 5.88% |
+1,068,371
| New | +$504M |
|
5
Carpenter Technology
CRS
$24.4B
| $525M | 5.82% |
1,330,920
-222,092
| -14% | -$80.9M |
|
|
6
Amazon
AMZN
$2.79T
| $492M | 5.46% |
2,363,334
-3,529,162
| -60% | -$777M |
|
7
Vulcan Materials
VMC
$35.8B
| $482M | 5.35% |
1,769,216
+809,043
| +84% | +$238M |
|
|
8
NVIDIA
NVDA
$5.2T
| $467M | 5.18% |
+2,675,018
| New | +$491M |
|
9
Interactive Brokers
IBKR
$42.5B
| $421M | 4.67% |
6,275,179
-664,402
| -10% | -$47.4M |
|
10
Amphenol
APH
$194B
| $363M | 4.03% |
2,871,353
-836,558
| -23% | -$118M |
|
11
CME Group
CME
$98.9B
| $349M | 3.88% |
1,182,907
+3,115
| +0.3% | +$925K |
|
12
Uber
UBER
$161B
| $335M | 3.71% |
4,652,363
+1,971,191
| +74% | +$152M |
|
|
13
Devon Energy
DVN
$54B
| $328M | 3.64% |
+6,525,140
| New | +$280M |
|
14
CRH
CRH
$63.2B
| $290M | 3.22% |
2,759,331
+498,271
| +22% | +$58.5M |
|
15
Canadian Natural Resources
CNQ
$106B
| $277M | 3.07% |
+5,690,211
| New | +$234M |
|
16
Mastercard
MA
$509B
| $230M | 2.55% |
459,652
+1,310
| +0.3% | +$690K |
|
|
MDLN
17
Medline Inc
MDLN
$30.1B
| $194M | 2.16% |
+4,365,802
| New | +$193M |
|
|
EMBJ
18
Embraer S.A. ADS
EMBJ
$13.5B
| $177M | 1.96% |
2,975,231
-302,909
| -9% | -$20.7M |
|
19
Ferguson
FERG
$46.9B
| $148M | 1.64% |
634,258
-374,056
| -37% | -$91M |
|
20
Lamar Advertising Co
LAMR
$15.3B
| $138M | 1.53% |
1,088,744
+366,661
| +51% | +$48M |
|
21
Arch Capital
ACGL
$33.9B
| $107M | 1.19% |
+1,116,922
| New | +$107M |
|
22
RenaissanceRe
RNR
$13.4B
| $94.3M | 1.05% |
317,308
-173,318
| -35% | -$50.3M |
|
23
New York Times
NYT
$10.6B
| $81.4M | 0.9% |
971,884
-438,119
| -31% | -$33.1M |
|
24
Armstrong World Industries
AWI
$7.55B
| $73.8M | 0.82% |
+448,036
| New | +$81.9M |
|
|
25
Boston Scientific
BSX
$73B
| – | – |
-5,385,084
| Closed | -$513M |
|
Similar funds
John Armitage's Q1 2026 Portfolio in Review
As of Q1 2026, John Armitage held 30 positions worth $9.01B, down 2.1% from $9.2B the previous quarter. Its ten largest holdings account for 69% of the portfolio.
John Armitage's Q1 2026 filing shows 7 new, 9 increased, 8 reduced and 6 closed positions. Its largest new stake was Linde: 1,068,371 shares worth $530M. The largest sale was Microsoft, an estimated $846M.
By sector, the portfolio is most concentrated in Financials at 35% of assets, down from 36% a quarter earlier, followed by Materials and Technology.
- John Armitage's largest Q1 2026 buy was Linde: 1,068,371 shares worth $530M.
- John Armitage added most to Alphabet (Google) Class C in Q1 2026, an estimated $748M increase.
- John Armitage's biggest Q1 2026 reduction was Amazon, cutting an estimated $777M.
- John Armitage fully exited Microsoft in Q1 2026, selling an estimated $846M.
- John Armitage's ten largest holdings make up 69% of its $9.01B portfolio in Q1 2026.
- John Armitage opened 7 new positions and closed 6 in Q1 2026.
- John Armitage's portfolio value fell 2.1% quarter-over-quarter to $9.01B.
Based on Egerton Capital (UK)'s 13F filing for Q1 2026, filed 13 May 2026.